The use of bevacizumab in pediatric retinal and choroidal disease: A review

Peter J. Belin; Andrew C. Lee; Giovanni Greaves; Jennifer Kosoy; Ronni M. Lieberman

doi:10.1177/1120672119827773

The use of bevacizumab in pediatric retinal and choroidal disease: A review

Peter J. Belin, Andrew C. Lee, Giovanni Greaves, Jennifer Kosoy, Ronni M. Lieberman

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The use of intravitreal bevacizumab in pediatric retinal and uveitic disease has become more widespread over the past decade. This article serves to outline the rationale underlying the use of intravitreal bevacizumab, and which disease entities it should be appropriately thought of as a primary or solo therapy, as opposed to an adjuvant one. Also presented is the relevant literature regarding each of these retinopathies.

Original language	English (US)
Pages (from-to)	338-347
Number of pages	10
Journal	European Journal of Ophthalmology
Volume	29
Issue number	3
DOIs	https://doi.org/10.1177/1120672119827773
State	Published - May 1 2019

All Science Journal Classification (ASJC) codes

Ophthalmology

Access to Document

10.1177/1120672119827773

Cite this

@article{0a047c0d5a7840edab73698e6b16e9b7,

title = "The use of bevacizumab in pediatric retinal and choroidal disease: A review",

abstract = "The use of intravitreal bevacizumab in pediatric retinal and uveitic disease has become more widespread over the past decade. This article serves to outline the rationale underlying the use of intravitreal bevacizumab, and which disease entities it should be appropriately thought of as a primary or solo therapy, as opposed to an adjuvant one. Also presented is the relevant literature regarding each of these retinopathies.",

author = "Belin, {Peter J.} and Lee, {Andrew C.} and Giovanni Greaves and Jennifer Kosoy and Lieberman, {Ronni M.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

month = may,

day = "1",

doi = "10.1177/1120672119827773",

language = "English (US)",

volume = "29",

pages = "338--347",

journal = "European Journal of Ophthalmology",

issn = "1120-6721",

publisher = "Wichtig Publishing",

number = "3",

}

TY - JOUR

T1 - The use of bevacizumab in pediatric retinal and choroidal disease

T2 - A review

AU - Belin, Peter J.

AU - Lee, Andrew C.

AU - Greaves, Giovanni

AU - Kosoy, Jennifer

AU - Lieberman, Ronni M.

N1 - Publisher Copyright: © The Author(s) 2019.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The use of intravitreal bevacizumab in pediatric retinal and uveitic disease has become more widespread over the past decade. This article serves to outline the rationale underlying the use of intravitreal bevacizumab, and which disease entities it should be appropriately thought of as a primary or solo therapy, as opposed to an adjuvant one. Also presented is the relevant literature regarding each of these retinopathies.

AB - The use of intravitreal bevacizumab in pediatric retinal and uveitic disease has become more widespread over the past decade. This article serves to outline the rationale underlying the use of intravitreal bevacizumab, and which disease entities it should be appropriately thought of as a primary or solo therapy, as opposed to an adjuvant one. Also presented is the relevant literature regarding each of these retinopathies.

UR - http://www.scopus.com/inward/record.url?scp=85061631766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061631766&partnerID=8YFLogxK

U2 - 10.1177/1120672119827773

DO - 10.1177/1120672119827773

M3 - Review article

C2 - 30757919

AN - SCOPUS:85061631766

SN - 1120-6721

VL - 29

SP - 338

EP - 347

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

IS - 3

ER -

The use of bevacizumab in pediatric retinal and choroidal disease: A review

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this